/SYNH

SYNH Stock - Syneos Health, Inc.

Q: What is the analyst price target for SYNH?

Analyst price target information is not currently available for SYNH.

Q: What is SYNH's market cap?

Market capitalization information is not currently available for SYNH.

Healthcare|Medical - Diagnostics & Research|NASDAQ

$42.98+0.02%

+$0.01 (+0.02%) • Sep 27

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+68.4%upside

Target: $72.38

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SYNH

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.58

52W High$52.23

52W Low$22.89

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	$5.39B	$5.21B	$4.42B	$4.68B	$4.39B
Gross Profit	$1.25B	$1.22B	$1.02B	$1.03B	$955.81M
Gross Margin	23.3%	23.4%	23.0%	22.0%	21.8%
Operating Income	$403.19M	$389.28M	$293.14M	$324.54M	$160.18M
Net Income	$266.50M	$234.83M	$192.79M	$131.26M	$24.28M
Net Margin	4.9%	4.5%	4.4%	2.8%	0.6%
EPS	$2.57	$2.26	$1.85	$1.27	$0.23

Company Overview

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

29%

Hold / Neutral

71%

Sell / Underperform

Analyst Consensus🔴 Bearish

2 Bullish5 Neutral/Bearish

Price Targets

$52

Average Target

↑ 21.5% Upside

Now

$25

Low

$52

Average

$102

High

Based on 10 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
February 13th 2023	JP Morgan	Downgrade	Underweight	$28← $30
January 17th 2023	Barclays	Downgrade	Underweight	$25← $30
January 13th 2023	Barclays	Downgrade	Underweight	$25
December 14th 2022	Mizuho	Downgrade	Neutral	$38← $66
November 7th 2022	Evercore ISI	Downgrade	In-line	$27← $55
October 18th 2022	JP Morgan	Downgrade	Neutral	$53← $85
September 14th 2022	Guggenheim	Downgrade	Neutral	-
September 7th 2022	UBS	Initiation	Neutral	$68
May 24th 2022	Guggenheim	Initiation	Buy	$81
April 25th 2022	Jefferies	Downgrade	Hold	$75← $101
April 12th 2022	Deutsche Bank	Initiation	Buy	$102

Earnings History & Surprises

SYNH

Beat Rate

88%

Last 17 quarters

Avg Surprise

+1.8%

EPS vs Estimate

Beats / Misses

15/2

Last 12 quarters

Latest EPS

$1.13

Q4 2023

EPS Surprise History

Q1 22

+3.5%

$1.48vs$1.43

Q2 22

+5.2%

$1.01vs$0.96

Q3 22

+4.2%

$1.25vs$1.20

Q4 22

-6.8%

$1.23vs$1.32

Q1 23

+4.2%

$1.23vs$1.18

Q2 23

+11.9%

$0.75vs$0.67

Q3 23

-98.7%

$0.01vs$0.78

Q4 23

+39.5%

$1.13vs$0.81

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2024	Aug 7, 2024	—	—	—	—
Q2 2024	May 8, 2024	—	—	—	—
Q1 2024	Feb 14, 2024	—	—	—	—
Q4 2023	Nov 2, 2023	$0.81	$1.13	+39.5%	✓ BEAT
Q3 2023	Aug 8, 2023	$0.78	$0.01	-98.7%	✗ MISS
Q2 2023	May 10, 2023	$0.67	$0.75	+11.9%	✓ BEAT
Q1 2023	Feb 16, 2023	$1.18	$1.23	+4.2%	✓ BEAT
Q4 2022	Nov 3, 2022	$1.32	$1.23	-6.8%	✗ MISS
Q3 2022	Aug 2, 2022	$1.20	$1.25	+4.2%	✓ BEAT
Q2 2022	Apr 29, 2022	$0.96	$1.01	+5.2%	✓ BEAT
Q1 2022	Feb 17, 2022	$1.43	$1.48	+3.5%	✓ BEAT
Q4 2021	Nov 3, 2021	$1.18	$1.22	+3.4%	✓ BEAT
Q3 2021	Aug 9, 2021	$0.94	$0.97	+3.2%	✓ BEAT
Q2 2021	Apr 29, 2021	$0.74	$0.79	+6.8%	✓ BEAT
Q1 2021	Feb 18, 2021	$1.10	$1.11	+0.9%	✓ BEAT
Q4 2020	Oct 29, 2020	$0.90	$1.04	+15.6%	✓ BEAT
Q3 2020	Aug 6, 2020	$0.48	$0.58	+20.8%	✓ BEAT
Q2 2020	Apr 30, 2020	$0.62	$0.68	+9.7%	✓ BEAT
Q1 2020	Feb 20, 2020	$1.01	$1.03	+2.0%	✓ BEAT
Q4 2019	Oct 31, 2019	$0.83	$0.87	+4.8%	✓ BEAT

Frequently Asked Questions about SYNH

What is SYNH's current stock price?

Syneos Health, Inc. (SYNH) is currently trading at $42.98 per share. The stock has moved +0.02% today.

What is the analyst price target for SYNH?

The average analyst price target for SYNH is $72.38, based on 1 analyst.

What sector is Syneos Health, Inc. in?

Syneos Health, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.

What is SYNH's market cap?

Syneos Health, Inc. has a market capitalization of $4.46 billion, making it a mid-cap company.

Does SYNH pay dividends?

No, Syneos Health, Inc. does not currently pay a dividend to shareholders.